News
-
-
-
COMMUNIQUÉ DE PRESSE
invIOs publishes positive clinical data on CBL-B-silenced autologous cell therapy APN401 in peer-reviewed journal
invIOs publishes positive clinical data on CBL-B-silenced autologous cell therapy APN401 in peer-reviewed journal. Study demonstrates safety and immune system enhancements for solid tumors -
-
-
-
-
-
-